Urinary Antiseptic Antibiotic
Pregnancy: Avoid at term — haemolytic anaemia in neonate; compatible in first and second trimester
Nitrofurantoin (Paediatric — UTI Prophylaxis)
Brand names: Macrobid, Furadantin
Adult dose
Dose: Treatment: 100 mg (MR) BD for 5 days or 50–100 mg QDS for 7 days. Prophylaxis: 50–100 mg OD at night
Route: Oral
Frequency: BD or QDS treatment; OD prophylaxis
Max: 400 mg/day treatment; 100 mg/day prophylaxis
Adult — do not use if eGFR <45 (reduced efficacy and drug accumulation risk)
Paediatric dose
Dose: 750 mcg/kg
Route: Oral
Frequency: QDS (treatment, 3–7 days); OD at night (prophylaxis)
Max: 100 mg per dose
Concentration: 25000 mcg/5 mL (25 mg/5 mL suspension) mcg/ml
BNF for Children: treatment 750 mcg/kg (= 0.75 mg/kg) QDS × 3–7 days (≥3 months), max 100 mg per dose. Prophylaxis (recurrent UTI/VUR): 1–2 mg/kg OD at night, max 100 mg. Do NOT use <3 months (haemolytic anaemia risk). Avoid in G6PD deficiency. Source: BNF for Children 2024; NICE NG224; RIVUR Trial (Hoberman, NEJM 2014)
Dose adjustments
Renal
Avoid if eGFR <45 — risk of drug accumulation and toxicity, and reduced urinary concentration (less effective)
Hepatic
Caution in hepatic impairment
Paediatric weight-based calculator
BNF for Children: treatment 750 mcg/kg (= 0.75 mg/kg) QDS × 3–7 days (≥3 months), max 100 mg per dose. Prophylaxis (recurrent UTI/VUR): 1–2 mg/kg OD at night, max 100 mg. Do NOT use <3 months (haemolytic anaemia risk). Avoid in G6PD deficiency. Source: BNF for Children 2024; NICE NG224; RIVUR Trial (Hoberman, NEJM 2014)
Clinical pearls
- Brown urine: reassure parents this is harmless and expected
- Pulmonary hypersensitivity: rare but serious — acute presentation (fever, dyspnoea, eosinophilia) within first month; chronic form (fibrosis) with prolonged use
- Prophylaxis: 1–2 mg/kg OD at night widely used for VUR-associated recurrent UTI — RIVUR trial supported prophylaxis reducing febrile UTI by 50%
- Avoid in G6PD deficiency — haemolytic anaemia risk
Contraindications
- Age <3 months
- G6PD deficiency
- Renal impairment (eGFR <45)
- Pulmonary function compromise (relative)
Side effects
- Nausea/vomiting (take with food)
- GI upset
- Pulmonary reactions (acute, subacute, or chronic — rare)
- Peripheral neuropathy (rare, prolonged use)
- Haemolytic anaemia (G6PD deficiency)
- Benign brown urine discolouration
Interactions
- Antacids (magnesium trisilicate) — reduce absorption
- Quinolones — mutual antagonism
Monitoring
- Urine culture if breakthrough UTI
- LFTs and pulmonary function if prolonged use
- Symptoms of peripheral neuropathy
Reference: BNF for Children; NICE NG224 UTI in Children; RIVUR Trial (Hoberman et al, NEJM 2014). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- PICU Delirium Assessment (pCAM-ICU) · Delirium Assessment
- Vasoactive-Inotropic Score (VIS) · Inotropic Support
- Caprini Score for VTE Risk (2005) · VTE Risk
- Lund-Browder Chart — TBSA Burn Estimation · Burns
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Caprini VTE Risk Assessment · Venous Thromboembolism